What are the most common infectious complications after autologous stem cell transplantation and how should prophylaxis and treatment be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Infectious Complications After Autologous Stem Cell Transplantation

In autologous HCT recipients, the most common infectious complications are bacterial infections (particularly during neutropenia), HSV reactivation, and Candida infections, with organ toxicity and infectious complications being the primary causes of non-relapse mortality. 1

Most Common Infectious Complications

Bacterial Infections

  • Fever occurs in 72-86% of patients after autologous HCT 2
  • Fever of unknown origin (FUO) represents 55-59% of all febrile episodes, with most being culture-negative 3, 2
  • When organisms are identified, Gram-positive bacteria account for approximately 67-69% of bloodstream infections 2
  • Bacterial infections are the leading cause of morbidity and mortality following autologous transplant 4

Viral Infections

  • HSV reactivation occurs in 60-80% of seropositive patients without prophylaxis, primarily during the early neutropenic phase 5
  • VZV reactivation risk extends through the first year post-transplant 5
  • CMV infections are uncommon in autologous HCT recipients (unlike allogeneic transplant) due to lack of post-transplant immunosuppression 1

Fungal Infections

  • Candida infections are the primary fungal concern, particularly in patients with mucositis 5
  • Invasive mold infections (Aspergillus) are rare in autologous HCT compared to allogeneic transplant 5

Prophylaxis Management

Antibacterial Prophylaxis

Fluoroquinolone prophylaxis (levofloxacin or ciprofloxacin) during neutropenia is commonly used but remains controversial 3, 2. The evidence shows:

  • No clear superiority between levofloxacin and ciprofloxacin in terms of infection rates or outcomes 2
  • Only 42% of pediatric centers routinely use bacterial prophylaxis during neutropenia, reflecting lack of consensus 6
  • Both approaches yield similar mortality rates and infection patterns 2

Antiviral Prophylaxis

HSV prophylaxis is strongly recommended during neutropenia for all HSV-seropositive patients 5:

  • Acyclovir, valacyclovir, or famciclovir are first-line agents
  • Continue throughout the neutropenic period

VZV prophylaxis should be extended for 6-12 months post-transplant in autologous HCT recipients 5:

  • Use the same agents as HSV prophylaxis (acyclovir, valacyclovir, or famciclovir)
  • Particularly important given the extended risk period beyond neutropenia recovery

Antifungal Prophylaxis

The approach depends on presence of mucositis 5:

For patients WITH mucositis:

  • Fluconazole or echinocandin (category 1 recommendation) until neutropenia resolves 5
  • Both are equally effective first-line options

For patients WITHOUT mucositis:

  • No antifungal prophylaxis is recommended 5

Important caveat: Fluconazole use can predispose to colonization with fluconazole-resistant Candida species, though this remains the standard of care 5

Treatment Approach

Empirical Antibiotic Therapy

When fever develops during neutropenia:

  • Broad-spectrum antibiotics are indicated immediately
  • Common regimens include ceftazidime-amikacin or meropenem 2
  • The choice should be guided by local resistance patterns and institutional protocols

Duration of Prophylaxis

Antifungal prophylaxis: Continue until neutropenia resolves (ANC >500) 5

Antiviral prophylaxis:

  • HSV: Throughout neutropenic period
  • VZV: 6-12 months post-transplant 5

Key Clinical Pitfalls

  1. Underestimating VZV risk: Unlike HSV which primarily reactivates during neutropenia, VZV risk extends well beyond neutrophil recovery—prophylaxis must continue for months 5

  2. Overuse of mold-active antifungals: Posaconazole and other mold-active agents are not indicated in routine autologous HCT; reserve these for allogeneic transplant or specific high-risk scenarios 5

  3. Assuming all fevers need cultures: With 55-59% being FUO, aggressive workup may not change management, though blood cultures remain essential 3

  4. Forgetting bortezomib-associated VZV risk: Patients receiving bortezomib (common in myeloma) have increased VZV reactivation risk and should receive prophylaxis during active therapy 5

Outcomes and Mortality

Transplant-related mortality is low (1.9-4.2%) in modern series, with infectious complications being the second leading cause after organ toxicity 1, 3. The majority of patients (>95%) do not require readmission for infections within 100 days of transplant when appropriate prophylaxis is used 3.

Autologous HCT carries significantly less infectious risk than allogeneic HCT because patients do not receive post-transplant immunosuppression and do not develop GVHD 1.

References

1
Guideline

hematopoietic cell transplantation, version 2.2020, nccn clinical practice guidelines in oncology.

Journal of the National Comprehensive Cancer Network : JNCCN, 2020

3
Research

Characteristics and outcome of infectious complications after autologous hematopoietic cell transplantation in multiple myeloma patients.

Transplant infectious disease : an official journal of the Transplantation Society, 2023

4
Research

Infectious complications during autotransplantation.

Hematology/oncology clinics of North America, 1993

Related Questions

What is the minimum recommended duration of antimicrobial therapy for a deep puncture wound?
A 10‑day postpartum woman presents with dysuria and a urine culture growing mixed microbiota >100,000 CFU/mL; how should this be managed?
What is the appropriate 10‑day antibiotic regimen for a patient undergoing ENT follow‑up after image‑guided fine‑needle aspiration/biopsy, assuming no documented β‑lactam allergy?
In a 10‑month‑old infant with a slightly indented coronal suture, normal fontanelles, and appropriate head growth, what is the appropriate next step in management?
Should an asymptomatic urine culture with 10,000–49,000 CFU/mL Escherichia coli be treated?
Will eating lobster affect the INR in a patient taking Coumadin (warfarin)?
What is the appropriate antibiotic regimen for acute mastitis in an adult lactating woman, including options for penicillin allergy and community‑acquired MRSA risk?
In patients with diabetes mellitus, how often should glycated hemoglobin (HbA1c) be measured?
What is the recommended protocol for tapering oral micronized progesterone from 200 mg to 100 mg?
A patient working outdoors in the yard has a heart rate of 150‑170 beats per minute (tachycardia). What immediate management and follow‑up recommendations are appropriate?
What is the appropriate management of a 22‑week pregnant woman with known epilepsy who presents with a seizure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.